TXNDC3/NME8 Antikörper (AA 1-446)

Produktnummer ABIN7869373

Der Kaninchen Polyklonal anti-TXNDC3/NME8 Antikörper (ABIN7869373) detektiert spezifisch TXNDC3/NME8 in ELISA, WB und FACS. Dieser Antikörper reagiert spezifisch mit Proben aus Human und Ratte.

Kurzübersicht für TXNDC3/NME8 Antikörper (AA 1-446) (ABIN7869373)

Target: TXNDC3/NME8 (TXNDC3) (Thioredoxin Domain Containing 3 (TXNDC3))

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TXNDC3/NME8 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Flow Cytometry (FACS)

Produktdetails anti-TXNDC3/NME8 Antikörper

Bindungsspezifität: AA 1-446

Verwendungszweck: NME8 Antibody / TXNDC3 / Thioredoxin domain-containing protein 3

Aufreinigung: Immunogen affinity purified

Immunogen: E.coli-derived human TXNDC3/NME8 recombinant protein (Position: M1-H446) was used as the immunogen for the NME8 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the NME8 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL

Buffer: Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: After reconstitution, the NME8 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Details zu TXNDC3/NME8

Target: TXNDC3/NME8 (TXNDC3) (Thioredoxin Domain Containing 3 (TXNDC3))

Andere Bezeichnung: NME8

Hintergrund: NME8 antibody detects Thioredoxin domain-containing protein 3, a microtubule-associated oxidoreductase that stabilizes axonemal structures in motile cilia. The UniProt recommended name is Thioredoxin domain-containing protein 3 (NME8). Also known as TXNDC3 or SPTRX2, this protein contains a thioredoxin-like domain and functions as part of the dynein regulatory complex involved in ciliary motility and organization.

Functionally, NME8 antibody identifies a 588-amino-acid protein localized to cilia and flagella, where it forms disulfide-linked complexes that maintain axonemal integrity. NME8 acts as a redox-active thioredoxin enzyme, regulating disulfide bond formation and stabilization of microtubule doublets. It is crucial for proper assembly of outer dynein arms, which generate the bending motion of motile cilia.

The NME8 gene is located on chromosome 7p14.1 and is expressed in ciliated tissues such as respiratory epithelium, oviduct, and testis. Through its thioredoxin activity, NME8 supports sperm motility, mucociliary clearance, and left-right body asymmetry during embryonic development.

Pathologically, mutations in NME8 cause primary ciliary dyskinesia (PCD), a disorder characterized by chronic respiratory infections, male infertility, and situs inversus due to impaired ciliary movement. Dysregulation of NME8 expression has also been implicated in neurodegenerative diseases such as Alzheimeri 1/2s, where it may influence axonal transport and oxidative stress. Research using NME8 antibody supports studies in ciliary biology, redox regulation, and cytoskeletal organization.

NME8 antibody is validated for western blotting, immunofluorescence, and immunohistochemistry to detect ciliary structural and redox-regulating proteins. NSJ Bioreagents provides NME8 antibody reagents optimized for cell motility, developmental, and oxidative stress research.

Structurally, Thioredoxin domain-containing protein 3 contains an N-terminal thioredoxin fold and multiple coiled-coil regions that mediate protein dimerization and microtubule binding. This antibody enables detailed study of NME8's role in ciliary structure and redox homeostasis.

UniProt: Q8N427

Pathways: Nucleotide Phosphorylation, Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis